Sonoma Pharmaceuticals (SNOA) Total Debt (2011 - 2025)

Sonoma Pharmaceuticals' Total Debt history runs 15 years deep, the most recent figure standing at $56000.0 for Q3 2025.

• In Q3 2025, Total Debt fell 31.71% year-over-year to $56000.0; the TTM figure through Sep 2025 stood at $56000.0 (down 31.71% YoY), while the FY2025 annual figure was $220000.0, down 31.89% from the prior year.
• Total Debt was $56000.0 for Q3 2025 at Sonoma Pharmaceuticals, down from $139000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $1.9 million in Q1 2021 to a low of $15000.0 in Q4 2022.
• Historically, Total Debt has averaged $346764.7 across 5 years, with a median of $220000.0 in 2025.
• Biggest YoY gain for Total Debt was 296.26% in 2021; the steepest drop was 85.36% in 2021.
• A 5-year view of Total Debt shows it stood at $199000.0 in 2021, then plunged by 92.46% to $15000.0 in 2022, then soared by 193.33% to $44000.0 in 2023, then surged by 86.36% to $82000.0 in 2024, then plunged by 31.71% to $56000.0 in 2025.
• The last three Total Debt figures came in at $56000.0 (Q3 2025), $139000.0 (Q2 2025), and $220000.0 (Q1 2025), per Business Quant data.